Lannett Co. Inc. appointed Timothy Crew as CEO, effective Jan. 2, 2018.
Arthur Bedrosian will continue to serve as CEO until Crew's appointment.
The board plans to appoint Crew as a director of the company after the completion of its 2018 annual shareholders meeting.
Crew joins Lannett from Cipla North America, where he served as CEO from 2013 to 2017. Before that he worked at Teva Pharmaceutical Industries Ltd.
